Overview
To date, there are highly effective lipid-lowering drugs, the combination of which makes it possible to achieve the target level of LDL-C in most patients with familial hypercholesterolemia (FH). However, the effectiveness of treatment of FH patients strongly depends on adherence to lipid-lowering therapy and to the healthy lifestyle, as well as the detection of the disease and the therapy prescription as early as possible, better in childhood. The aim of the study is to assess the impact of genetic testing and motivational counseling on the effectiveness of treatment and cascade screening in patients with FH.
Description
There are several tasks of the study:
- To assess the effect of knowledge of patients with FH about the result of their FH genetic testing on the adherence to a healthy lifestyle and hypolipidemic therapy.
- To assess the impact of knowledge of patients with FH about the result of their FH genetic testing on the effectiveness of cascade screening.
- To assess the influence of motivational counseling of patients with FH on the adherence to a healthy lifestyle and hypolipidemic therapy.
- To assess the impact of motivational counseling of patients with FH on the effectiveness of cascade screening.
Eligibility
Inclusion Criteria:
- Probable or definite diagnosis of FH according to the Dutch criteria (6 points or more);
- Signed informed consent;
Exclusion Criteria:
- Pregnancy or lactation at the time of enrollment
- Established active severe infectious disease or severe hematologic, metabolic, gastrointestinal or endocrine dysfunctions (for example, uncontrolled thyroid dysfunction or uncontrolled diabetes mellitus) in the opinion of the investigator
- Active liver disease
- Estimated GFR≤ 30 ml / min / 1.73m2
- Any other conditions at Visit 1 that, according to the investigator's opinion, render the patient ineligible for inclusion in the study, may interfere with the patient's participation in the study or patient's completion of the study.